Berge, NO
Arvid Berge, Trondheim NO
Patent application number | Description | Published |
---|---|---|
20130035418 | PROCESS FOR THE PREPARATION OF MONODISPERSE POLYMER PARTICLES - A process for the preparation of monodisperse polymer particles which are formed by contacting monomers with aqueous dispersions comprising monodisperse swellable seed polymers/oligomers, and initiating polymerization in the presence of a steric stabilizer. The resulting swollen seed particles are characterized by the particle mode diameter. | 02-07-2013 |
20140256836 | PROCESS FOR THE PREPARATION OF MONODISPERSE POLYMER PARTICLES - A process for the preparation of monodisperse polymer particles which are formed by contacting monomers with aqueous dispersions comprising monodisperse swellable seed polymers/oligomers, and initiating polymerization in the presence of a steric stabilizer. The resulting swollen seed particles are characterized by the particle mode diameter. | 09-11-2014 |
Arvid Trygve Berge, Trandheim NO
Patent application number | Description | Published |
---|---|---|
20090291506 | PROCESS - A process for the preparation of coated polymer particles containing superparamagnetic crystals, said process comprising reacting surface-functionalized, superparamagnetic crystal-containing polymer particles of diameter less than 0.5 μm with at least one polyisocyanate and at least one diol. | 11-26-2009 |
Arvid Trygve Berge, Trondheim NO
Patent application number | Description | Published |
---|---|---|
20100099803 | PROCESS FOR THE PREPARATION OF MONODISPERSE POLYMER PARTICLES - A process for the preparation of monodisperse polymer particles which are formed by contacting monomers with aqueous dispersions comprising monodisperse swellable seed polymers/oligomers, and initiating polymerization in the presence of a steric stabilizer. The resulting swollen seed particles are characterized by the particle mode diameter. | 04-22-2010 |
Astrid B. Berge, Asker NO
Patent application number | Description | Published |
---|---|---|
20100303914 | Self-Gelling Alginate Systems and Uses Thereof - Kits and compositions for producing an alginate gel are disclosed. The kits and compositions comprise soluble alginate and insoluble alginate/gelling ion particles. Methods for dispensing a self-gelling alginate dispersion are disclosed. The methods comprise forming a dispersion of insoluble alginate/gelling ion particles in a solution containing soluble alginate, and dispensing the dispersion whereby the dispersion forms an alginate gel matrix. The methods may include dispensing the dispersion into the body of an individual. An alginate gel having a thickness of greater than 5 mm and a homogenous alginate matrix network and homogenous alginate gels free of one or more of: sulfates citrates, phosphates, lactatates, EDTA or lipids are disclosed. Implantable devices comprising a homogenous alginate gel coating are disclosed. Methods of improving the viability of pancreatic islets, or other cellular aggregates or tissue, following isolation and during storage and transport are disclosed. | 12-02-2010 |
20130288998 | Self-Gelling Alginate Systems and Uses Thereof - Kits and compositions for producing an alginate gel are disclosed. The kits and compositions comprise soluble alginate and insoluble alginate/gelling ion particles. Methods for dispensing a self-gelling alginate dispersion are disclosed. The methods comprise forming a dispersion of insoluble alginate/gelling ion particles in a solution containing soluble alginate, and dispensing the dispersion whereby the dispersion forms an alginate gel matrix. The methods may include dispensing the dispersion into the body of an individual. An alginate gel having a thickness of greater than 5 mm and a homogenous alginate matrix network and homogenous alginate gels free of one or more of: sulfates citrates, phosphates, lactatates, EDTA or lipids are disclosed. Implantable devices comprising a homogenous alginate gel coating are disclosed. Methods of improving the viability of pancreatic islets, or other cellular aggregates or tissue, following isolation and during storage and transport are disclosed. | 10-31-2013 |
20140271576 | Self-Gelling Alginate Systems and Uses Thereof - Kits and compositions for producing an alginate gel are disclosed. The kits and compositions comprise soluble alginate and insoluble alginate/gelling ion particles. Methods for dispensing a self-gelling alginate dispersion are disclosed. The methods comprise forming a dispersion of insoluble alginate/gelling ion particles in a solution containing soluble alginate, and dispensing the dispersion whereby the dispersion forms an alginate gel matrix. The methods may include dispensing the dispersion into the body of an individual. An alginate gel having a thickness of greater than 5 mm and a homogenous alginate matrix network and homogenous alginate gels free of one or more of: sulfates citrates, phosphates, lactatates, EDTA or lipids are disclosed. Implantable devices comprising a homogenous alginate gel coating are disclosed. Methods of improving the viability of pancreatic islets, or other cellular aggregates or tissue, following isolation and during storage and transport are disclosed. | 09-18-2014 |
Erik Magistad Berge, Rasta NO
Patent application number | Description | Published |
---|---|---|
20090232939 | COMPOSITION COMPRISING SUGAR AND SALT FOR TREATING MEAT - The present invention relates to a composition comprising a mixture of sugar and salt for treating meat. Treating meat either by penetration of said composition through the meat or by fermenting the meat in a closed container, results in a meat product with a salty taste throughout. Processes using lactic acid fermentation and process for producing storage-stable meat products are also disclosed. | 09-17-2009 |
Gerd Berge, Tromso NO
Patent application number | Description | Published |
---|---|---|
20140037657 | INHIBITION OF TUMOR GROWTH - The present invention provides a cytotoxic 7 to 25 mer peptide with three or more cationic residues which has one or more non-genetic bulky and lipophilic amino acids, as well as esters, amides, salts and cyclic derivatives thereof as well as methods of preparing the peptides, pharmaceutical compositions containing them and their use as medicaments, particularly as antibacterions or antitumoral agents. In a preferred aspect, the invention provides the use of said peptides in a method of inducing adaptive immunity against tumor growth or establishment in a subject, as well as the use of other lytic agents in a method of inducing adaptive immunity in a subject. | 02-06-2014 |
Gunnar Berge, Oslo NO
Patent application number | Description | Published |
---|---|---|
20100062057 | Formulation - Novel capsules comprising a marine oil in an outer shell comprising alginate are disclosed. Also disclosed are methods of preparing the novel capsules and uses of thereof. | 03-11-2010 |
20110262534 | POLYSACCHARIDE CAPSULE ENCLOSING A FATTY ACID OIL-CONTAINING EMULSION - Novel capsules where an outer shell comprises a polysaccharide, e.g. an alginate. In the capsules there is an emulsion comprising a fatty acid oil mixture and at least one surfactant. Preferred fatty acid oils are eicosapentaenoic acid (EPA) and doccosahexaenoic acid (DHA). | 10-27-2011 |
20120196934 | COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE COMPRISING EPA AND DHA IN FREE ACID FORM AND A SURFACTANT, AND METHODS AND USES THEREOF - Preconcentrates comprising a fatty acid oil mixture and at least one surfactant, and methods and uses thereof are disclosed. The preconcentrates are capable of forming a self-nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS), or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. | 08-02-2012 |
20120225945 | COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A SURFACTANT, AND METHODS AND USES THEREOF - A preconcentrate comprising a fatty acid oil mixture that contains EPA and DHA, preferably in the form of ethyl ester or triglyceride, and at least one surfactant. The preconcentrates are capable of forming a self-nanoemulsifying drug delivery system, a self-microemulsifying drug delivery system or a self-emulsifying drug delivery system (SNEDDS, SMEDDS or SEDDS) in an aqueous solution. The application is also directed to a food supplement preconcentrate. | 09-06-2012 |
20120232141 | COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A FREE FATTY ACID, AND METHODS AND USES THEREOF - Compositions comprising a fatty acid oil mixture and at least one free fatty acid, and uses thereof are disclosed. Further disclosed are preconcentrates capable of forming a self-nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS) or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. Preferred fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in a form chosen from ethyl ester and triglyceride. | 09-13-2012 |
20130108696 | COATED CAPSULES AND TABLETS OF A FATTY ACID OIL MIXTURE | 05-02-2013 |
20140004186 | COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE COMPRISING EPA AND DHA IN FREE ACID FORM, A SURFACTANT, AND A STATIN | 01-02-2014 |
20140017308 | COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE, A FREE FATTY ACID, AND A STATIN - Compositions comprising a fatty acid oil mixture, at least one free fatty acid, and at least one statin or pharmaceutically acceptable salt, hydrate, solvate, or complex thereof, and uses thereof are disclosed. Further disclosed are preconcentrates capable of forming a self-nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS), or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. | 01-16-2014 |
Jan Olav Berge, Haugesund NO
Johan Gerhard Berge, Langhus NO
Patent application number | Description | Published |
---|---|---|
20080319726 | SYSTEM AND METHOD FOR PERFORMING OILFIELD SIMULATION OPERATIONS - The invention relates to a method of performing a gas operation of an oilfield having a subterranean formation with at least one reservoir positioned therein. The method steps include modeling the gas operation of the oilfield using a multi-domain simulator by coupling a static model of the subterranean formation, a dynamic model of the subterranean formation, and a well model, wherein the multi-domain simulator comprises the static model, the dynamic model, and the well model, defining a development plan for the gas operation based on the modeling, and performing gas injection according to the development plan. | 12-25-2008 |
Kjetil Berge, Oslo NO
Patent application number | Description | Published |
---|---|---|
20140080791 | OMEGA-3 PHOSPHOLIPID SUPPLEMENTS FOR FEMALES - The invention relates to omega-3 phospholipid supplements for females, and in particular to omega-3 phospholipid supplements with increased bioavailability as evidenced by increased EPA and DHA in plasma phospholipids and an increase in omega-3 index as compared to males. In preferred embodiments, the omega-3 phospholipid is krill oil. | 03-20-2014 |
20140088043 | OMEGA-3 COMPOSITIONS - The present invention relates to compositions comprising omega-3 fatty acid derivatives, and in particular to compositions comprising omega-3 phospholipids in combination with other omega-3 derivatives. | 03-27-2014 |
20140274968 | OMEGA-3 PHOSPHOLIPID SUPPLEMENTS FOR IMPROVED BRAIN MATURITY - The invention relates to omega-3 phospholipid supplements for use in adolescents, and in particular to use omega-3 phospholipid supplements to improve or support brain maturity age. In preferred embodiments, the omega-3 phospholipid is krill oil. | 09-18-2014 |
Olav Magnus Berge, Skoppum NO
Patent application number | Description | Published |
---|---|---|
20120026828 | CONTROL DEVICE FOR POSITIONING AN INSTRUMENTED CABLE TOWED IN WATER - Control device ( | 02-02-2012 |
Roar Berge, Kristiansand S NO
Patent application number | Description | Published |
---|---|---|
20130220367 | Method and Device for Treatment of a Pipestring Section that is Positioned in a Set-Back - A method for treating pipe string sections being in a set-back and being arranged in a vertical position comprises arranging a remote-controllable manipulator at least at one of the threaded portions of the pipe string sections. In addition, the method comprises providing the remote-controllable manipulator with a tool. The tool is arranged to at least clean or lubricate said threaded portion. Further, the method comprises moving the tool to a threaded portion which is to be treated and at least clean or lubricate the threaded portion. | 08-29-2013 |
Roar Berge, Kristiansano NO
Patent application number | Description | Published |
---|---|---|
20090211404 | Spinning wrench systems - An apparatus for rotating a tubular, the apparatus, in at least certain aspects including having a plurality of tubular-contacting rollers with one or more pairs of interlaced rollers. This Abstract is provided to comply with the rules requiring an abstract which will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure and is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims, 37 C.F.R. 1.72(b). | 08-27-2009 |
Rolf Berge, Norway NO
Patent application number | Description | Published |
---|---|---|
20120101161 | FATTY ACID ANALOGUES FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISORDERS - The present invention relates to fatty acid analogues of the general formula R | 04-26-2012 |
Rolf Berge, Bones NO
Patent application number | Description | Published |
---|---|---|
20100029973 | Fatty acid analogues for equilibrating bone mineral density - The invention comprises the use of compounds comprising non β-oxidizable fatty acid entities according to formula (I) or (II) for the preparation of a pharmaceutical composition for the prevention and/or treatment of conditions associated with low/decreased bone mineral density (BMD), and/or for increasing the BMD by decreasing the bone resorption. | 02-04-2010 |
20120276212 | COMPOSITION COMPRISING PLANT AND/OR FISH OILS AND NON-OXIDIZABLE FATTY ACID ENTITIES - The present invention concerns a composition prepared from a combination of plant oil and/or fish oil and a compound comprising non. β-oxidizable fatty acid analogues, and the use of said composition for the preparation of a pharmaceutical or nutritional composition for the prevention and/or treatment of insulin resistance, obesity, diabetes, fatty liver, hypercholesterolemia, dyslipidemia, atherosclerosis, coronary heart disease, thrombosis, stenosis, secondary stenosis, myocardial infarction, stroke, elevated blood pressure, endothelial dysfunction, procoagulant state, polycystic ovary syndrome, the metabolic syndrome, cancer, inflammatory disorders and proliferate skin disorders. The present invention also concerns an animal feed prepared from a combination of plant oil and/or fish oil and a compound comprising non β-oxidizable fatty acid analogues, the use of said feed for improving the body composition of an animal, and a product produced from said animal. | 11-01-2012 |
Rolf Kristian Berge, Bones NO
Patent application number | Description | Published |
---|---|---|
20120264966 | SULFUR-CONTAINING PHOSPHOLIPID DERIVATIVES - The present invention provides a lipid compound comprising at least one non-polar moiety and a polar moiety, wherein each or at least one non-polar moiety is of the formula X—Y—Z, wherein X is a hydrocarbyl chain, Y is selected from at least one of S, Se, SO | 10-18-2012 |
Svein Berge, Oslo NO
Patent application number | Description | Published |
---|---|---|
20100329466 | DEVICE AND METHOD FOR CONVERTING SPATIAL AUDIO SIGNAL - An audio processor for converting a multi-channel audio input signal, such as a B-format sound field signal, into a set of audio output signals, such as a set of two or more audio output signals arranged for headphone reproduction or for playback over an array of loudspeakers. A filter bank splits each of the input channels into frequency bands. The input signal is decomposed into plane waves to determine one or two dominant sound source directions. The(se) are used to determine a set of virtual loudspeaker positions selected such that the dominant direction(s) coincide(s) with virtual loudspeaker positions. The input signal is decoded into virtual loudspeaker signals corresponding to each of the virtual loudspeaker positions, and the virtual loudspeaker signals are processed with transfer functions suitable to create the illusion of sound emanating from the directions of the virtual loudspeakers. A high spatial fidelity is obtained due to the coincidence of virtual loudspeaker positions and the determined dominant sound source direction(s). Improved performance can be obtained in the case where Head-Related Transfer Functions are used by differentiating the phase of a high frequency part of the HRTFs with respect to frequency, followed by a corresponding integration of this part with respect to frequency after combining the components of HRTFs from different directions. | 12-30-2010 |
Thomas Berge, Hafrsfjord NO
Patent application number | Description | Published |
---|---|---|
20150267491 | Downhole Actuator Device - A downhole actuator device comprises a central shaft formed with external threads; a sleeve formed with internal threads and placed substantially concentrically around the shaft and an electromotor arranged to rotate at least a first one of said shaft and said sleeve so that a second one of said shaft and said sleeve may be moved linearly relative to the first one of said shaft and said sleeve. The actuator further comprises a plurality of roller screws that are rotatingly supported between the shall and sleeve in engagement with said external threads on the shaft and said internal threads on the sleeve. | 09-24-2015 |